Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jennerex appoints Dr James Burke VP of clinical research

This article was originally published in Scrip

Executive Summary

Jennerex, a San Francisco-based cancer biotherapeutics company, has appointed Dr James Burke to the newly-created position of vice-president of clinical research; he will be responsible for global clinical research activities related to Jennerex' pipeline. Dr Burke, who has 20 years' experience in the clinical science of genetic and immunotherapy, has been working with Jennerex in an advisory capacity as a clinical advisor for more than a year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC012048

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel